New Pharmaceutical Plant Will Be Built in Prevalje
The Lek Company owned by Novartis Group (Switzerland) will build a new plant in Prevalje. The construction budget is estimated at 105 million euros.
The foundation stone was laid symbolically on the site of the pharmaceutical plant construction. The Lek’s leaders and the Prime Minister of Slovenia Miro Cerar attended the solemn event.
The construction of a pharmaceutical plant in Slovenia will increase the production of broad-spectrum antibiotics that have been produced in Prevalje for over 40 years. The first phase of construction and launch of mass production are planned for implementation in 2020. In general, the investment project should be completed before 2023, as noted by the Chairman of the Lek Company Board Vojmir Ulep.
The project is the largest investment by Novartis in Slovenia today. According to Ulep, 140 new job places will be opened, and the first employees will be admitted to the company this summer. In total, Lek’s staff in Prevalje currently involves 246 employees. Vojmir Ulep stresses that the investment project is designed taking into account the modern environmental requirements and excludes the negative impact of production on the environment and human health.
Completion of the first phase of construction will allow Lek to increase its annual output from 600–700 million tablets to 1.5 billion. In addition, within the framework of the investment project, a new warehouse will be built, which in the first stage will have room for storing about 2,000 pellets.
During the solemn laying of the foundation stone, Miro Cerar noted that the project for the construction of a new plant was a powerful impetus for the growth of foreign investment in Slovenia and the further development of business in Prevalje, Carinthia and all Slovenia.